Incisional Negative Pressure Wound Therapy for Prevention of Postoperative Infections Following Caesarean Section

January 30, 2017 updated by: Nana Hyldig, Odense University Hospital

Use of Incisional Negative Pressure Wound Therapy for Prevention of Postoperative Infections Following Caesarean Section in Women With BMI >=30

The purpose of this study is to examine whether obese women (BMI >= 30) who give birth by caesarean section have a reduced incidence of wound infection and dehiscence when incisional Negative Pressure Wound Therapy is applied prophylactically following caesarean section.

Study Overview

Detailed Description

This study is a non-blinded randomised controlled trial and a concurrent Health Economic Evaluation. The study examines the effect on wound healing using incisional Negative Pressure Wound Therapy (iNPWT) compared with standard postoperative dressings in women with a BMI >= 30, who has a Caesarean Section (CS). We expect to find a lower frequency of wound complications when using iNPWT directly on primary suturing compared to standard postoperative dressings in this high-risk subpopulation.

Women, who have given informed consent, will be randomised to either intervention or control group via a computer-generated randomisation program. Elective and emergency CS will be stratified to ensure roughly equal numbers in each category of CS in each arm of the study and permit valid separate and pooled analysis. The analysis will be carried out on an intention to treat basis.

The iNPWT or standard postoperative dressings will be applied in theatre immediately following the operation. In the intervention group the therapy will be left in situ for five days corresponding to the date of removal of stitches. In the control group the dressing will be left in situ for at least 24 hours as standard procedure. Women, who do not wish to participate, will be asked for permission to use their data in the analysis.

Study Type

Interventional

Enrollment (Actual)

876

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hvidovre, Denmark, 2650
        • Hvidovre Hospital
      • Odense, Denmark, 5000
        • Odense University Hospital
    • Jutland
      • Aarhus, Jutland, Denmark, 8200
        • Aarhus University Hospital
      • Esbjerg, Jutland, Denmark, 6700
        • Hospital South West Jutland
      • Kolding, Jutland, Denmark, 6000
        • Hospital Lillebaelt, Kolding Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Age ≥ 18 year
  • Women who can read and understand Danish
  • pregestational BMI ≥ 30 kg/m2

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: iNPWT
Negative Pressure Wound Therapy (NPWT) is a mechanical wound care treatment using controlled sub-atmospheric pressure to assist and accelerate wound healing. Incisional Negative Pressure Wound Therapy (iNPWT) is a new NPWT devices, which can be used over clean closed surgical incisions. The device behaves in a similar fashion to existing conventional NPWT devices, i.e. transmission of negative pressure levels at the wound bed, tissue contraction and establishing a characteristic pattern of peri-wound blood flow and that it reduces and normalises tissue stresses at the incision
The Incisional Negative Pressure Wound Therapy (iNPWT) will be applied over the clean closed incision immediately following the operation (caesarean section). In the intervention group the therapy will be left in situ for five days.
Other Names:
  • incisional Negative Pressure Wound Therapy
Active Comparator: Standard wound dressing
The standard postoperative wound dressing is a normal wound dressing, used over clean closed incisions.
A standard wound dressing will be applied over the clean closed incision immediately following the operation (caesarean section). In the control group the dressing will be left in situ for at least 24 hours as standard procedure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of post-CS wound infection in each study group
Time Frame: Within the first 30 days after surgery

Wound infection requiring antibiotic treatment

To be able to collect information about symptoms of infection after discharge a self-administered questionnaire will be sent to all participants within 30 days post-CS. Furthermore data on postoperative infections, recorded by diagnoses codes or surgical procedures, will be obtained from the Danish National Patient Registry

Within the first 30 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of the primary and any secondary hospitalization
Time Frame: Within the first 30 days after Caesarean Section
Primary for the health economic evaluation
Within the first 30 days after Caesarean Section
Readmissions to hospital/contact to the general practitioner on suspicion of infection following caesarean section
Time Frame: Within the first 30 days after Caesarean Section
Primary for the health economic evaluation
Within the first 30 days after Caesarean Section
Number of Participants with a decreased health-related quality of life score as a measure of satisfaction and tolerability
Time Frame: Within the first 30 days after Caesarean Section
A health-related quality of life measure, recorded in Quality Adjusted Life Years at the two interventions. The health-related quality of life score is measured 5 and 30 days post-CS. Primary for the health economic evaluation
Within the first 30 days after Caesarean Section
Antibiotic treatment on suspicion of infection after Caesarean Section
Time Frame: Within the first 30 days after Caesarean Section
Primary for the health economic evaluation
Within the first 30 days after Caesarean Section
The cosmetic outcome as a measure of satisfaction
Time Frame: A 6 and 12 months follow-up
The scar will be evaluated by a plastic surgeon at a clinical examination 6 and 12 months post-CS. After study completion pictures of the scars will be evaluated by two unbiased plastic surgeons, using two predefined scar scales.
A 6 and 12 months follow-up
Other wound complications after caesarean section
Time Frame: Within the first 30 days after Caesarean Section
wound separation, wound exudate
Within the first 30 days after Caesarean Section

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 10, 2013

Primary Completion (Actual)

October 13, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

June 27, 2013

First Submitted That Met QC Criteria

July 1, 2013

First Posted (Estimate)

July 2, 2013

Study Record Updates

Last Update Posted (Estimate)

January 31, 2017

Last Update Submitted That Met QC Criteria

January 30, 2017

Last Verified

January 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgical Wound Infection

Clinical Trials on iNPWT

Subscribe